Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia
January 4, 2023
Researchers from Astellas Pharma Inc. investigated the efficacy of a novel antibody drug conjugate combined with venetoclax and azacitidine in a mouse model of acute myeloid leukemia. continue reading »